NeoGenomics, Inc.
NEO
|
NASDAQ
|
0 Followers
Company Quality
Profitability Score
17/100
Solvency Score
52/100
Dividends
Dividends data currently unavailable.Earnings
8/4/2025
in 49 days
-
Revenue est.
0.04
EPS est.
My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sector
Medical - Diagnostics & Research
Industry
Mr. Anthony P. Zook
CEO
2200
Employees
Fort Myers
Headquarters
US
Country
Key Metrics TTM
Valuation
Market cap.
$182MEnterprise Value
$441MPrice to Earnings
-2.32Price to Sales
0.27Price to Book
0.20Price to Cash Flow
-5.62Profitability
Return on Assets
-4.84%Return on Equity
-8.59%Return on Invested Capital
-5.69%Gross Margin
43.79%Operating Margin
-13.06%Net Margin
-11.54%Liquidity
Quick Ratio
1.95Current Ratio
2.05Cash Ratio
1.24Inventory Turnover
12.69Asset Turnover
0.42Total Liabilities
$713MSolvency
Debt to Assets
0.38Debt to Equity
N/AInterest Coverage
-13.41Equity Ratio
0.55Long-term Debt to Cap.
0.28Altman Z-Score
0.65Performance
Earnings Waterfall
Debt level and coverage
Earnings
Feed
There are no posts to show right now.